Grace Science Foundation
Biotechnology ResearchCalifornia, United States2-10 Employees
Grace Science Foundation is a small biotechnology research organization based in San Francisco, California. It was formed after Grace Wilsey's diagnosis with NGLY1 Deficiency in 2013, and its mission centers on pursuing faster, less costly, and more collaborative approaches to scientific exploration. It seeks to advance cures not only for NGLY1 Deficiency but also to apply its methods to other diseases, aiming for broader medical impact. Positioned within the biotechnology research sector, the foundation acts as a catalyst for collaborative, cost-conscious science. Its description suggests the work is intended to extend benefits beyond a single patient group to broader populations.